Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DKK1 in multiple myeloma

Michael A Meyer

    The New England Journal of Medicine
    |April 9, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    COSPAR Sample Safety Assessment Framework (SSAF).

    Astrobiology·2022
    Same author

    The Scientific Importance of Returning Airfall Dust as a Part of Mars Sample Return (MSR).

    Astrobiology·2021
    Same author

    Rationale and Proposed Design for a Mars Sample Return (MSR) Science Program.

    Astrobiology·2021
    Same author

    Science and Curation Considerations for the Design of a Mars Sample Return (MSR) Sample Receiving Facility (SRF).

    Astrobiology·2021
    Same author

    Final Report of the Mars Sample Return Science Planning Group 2 (MSPG2).

    Astrobiology·2021
    Same author

    Time-Sensitive Aspects of Mars Sample Return (MSR) Science.

    Astrobiology·2021
    Same journal

    Advances in Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.

    The New England journal of medicine·2026
    Same journal

    Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

    The New England journal of medicine·2026
    Same journal

    Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.

    The New England journal of medicine·2026
    See all related articles